3 recruiting, 2 active not recruiting, 1 not yet recruiting. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Recruiting 3, Active not recruiting 2, Not yet recruiting 1 |
Follow Nerandomilast: new trials by email Literature Review of Nerandomilast trials Research Report on Nerandomilast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies Placebo, Nerandomilast - Idiopathic Inflammatory Myopathies | Phase 3 | Not yet recruiting | Boehringer Ingelheim | 270 | 2026-12-14 | 2026-10-29 |
| FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression Nerandomilast, Placebo matching nerandomilast - Interstitial Lung Diseases | Phase 3 | Recruiting | Boehringer Ingelheim | 466 | 2026-09-17 | 2026-10-28 |
| A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD) Nerandomilast, Placebo - Fibrosing Interstitial Lung Disease | Phase 3 | Recruiting | Boehringer Ingelheim | 35 | 2026-07-21 | 2026-10-27 |
| A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis Nerandomilast, Placebo - Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities | Phase 3 | Recruiting | Boehringer Ingelheim | 80 | 2026-02-10 | 2026-10-28 |
| A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases Nerandomilast, Placebo matching nerandomilast - Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases | Phase 3 | Active not recruiting | Boehringer Ingelheim | 414 | 2025-09-13 | 2026-10-28 |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast Nerandomilast - Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis | Phase 3 | Active not recruiting | Boehringer Ingelheim | 1666 | 2024-09-26 | 2026-10-28 |
Lung Diseases, Interstitial (3) · Idiopathic Pulmonary Fibrosis (1) · Myositis (1)
Australia (6) · France (6) · Germany (6) · Italy (6) · Japan (6) · Netherlands (6) · South Korea (6) · Spain (6) · United Kingdom (6) · United States (6) · Argentina (5) · Belgium (5) · Canada (5) · China (5) · Mexico (5)
2025 (2), 2023 (1)